|
Market Closed -
Boerse Muenchen
16:43:56 2026-09-28 EDT
|
5-day change | 1st Jan Change | ||
| 12.70 EUR | +1.60% |
|
+4.17% | +37.36% |
| 09-28 | Bayer Receives U.S. FDA Acceptance And Priority Review For Supplemental New Drug Application For Lynkuet For A New Indication | CI |
| 09-24 | Hansa Biopharma brings in two new board members | FW |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Bayer AG(BAYN)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
Bayer AG(BAYN)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Bayer AG(BAYN)
EBIT
Dividend / Share (DPS)
Data source:
Bayer AG(BAYN)
Cash or Net Debt
- Stock Market
- Stocks
- BAYN Stock
- BAYA Stock
- Consensus Bayer AG
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
